Marathon Faces Scrutiny for Price of Muscular Dystrophy Drug

A group of U.S. senators is examining Marathon Pharmaceuticals LLC ’s decision to charge $89,000 in the U.S. for an old steroidal drug that costs a fraction of that overseas, the latest sign of growing scrutiny of the company.
Source: WSJ.com: Health - Category: Pharmaceuticals Tags: FREE Source Type: news